TÜSEB and Malaysia Committee Meeting
Last Added News
- Agreement Has Been Signed Between TÜSEB and USHAŞ for the International Provision of Accreditation Services
- The Memorandum of Understanding on Health Research Signed Between the Republic of Türkiye Ministry of Health, TÜSEB, and IHME.
- Türkiye–Uk Bilateral Meeting On Strengthening General Immunization And Lifelong Vaccine Uptake Convened In Ankara
- Tüseb And Social Security Institution (SGK) Launch Strategic Partnership Protocol Focused On Health Policy Development And Healthcare Financing
- Under The Framework Of The Century Of Healthy Türkiye – Innovative Health Model, The Tüseb Technology Transfer Office Antalya City Hospital Branch Has Commenced Operations
- Detailed Specifications For 2026 Tüseb Project Support Calls Have Been Published!
- Inauguration Of Antalya City Hospital Branch Of The Health Institutes Of Türkiye (Tüseb) Technology Transfer Office
- Training Program Conducted By Tüseb Technology Transfer Office (TTO) For The Personnel Of City Hospital Tto Branch Offices
- Launch Of The 2026 International Joint Call For ‘Multi-Country Investigator-Initiated Clinical Trials In Cardiovascular, Autoimmune, And Metabolic Diseases’ Under The Era4health Partnership
- PRELIMINARY INFORMATION ON THE 2026 CALL CALENDAR RELEASED
- ALL NEWS
The first domestic COVID-19 vaccine-named TURKOVAC, which was domestically produced with the support of TÜSEB and the domestic SARS-CoV-2 PCR diagnostic kit DiaKit, developed with national opportunities by Türkiye Biotechnology Institute were discussed on the use of them in Malaysia.
Committee were informed on TURKOVAC.